You are here

Power vacuum, Alzheimer's trials fuelling Biogen takeover rumours

But analysts remain sceptical Merck & Co and Allergan will actually make an offer for the drugmaker
Friday, August 5, 2016 - 05:50

BT_20160805_BIOGEN_2422969.jpg
The experimental therapies Biogen is developing include treatments for Alzheimer's disease - a market with vast potential.

Washington

ON July 21, as Biogen chief executive officer George Scangos announced he would step down, he floated the idea that his company might buy rivals to cement its place near the top of the booming field of biotechnology. Today, Biogen looks more like prey than predator.

sentifi.com

Market voices on:

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom